Foresight Biotherapeutics, Inc. — Form D
Foresight Biotherapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-13. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-11-13
- Form: D
- Accession: 0001526947-13-000003
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $15.0M
- Amount sold: $15.0M
- Minimum investment: $15.0M
- Investors: 2
- Date of first sale: 2013-10-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-206282
Issuer
- Name: Foresight Biotherapeutics, Inc.
- CIK: 0001526947
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 50 WEST 57TH STREET, NEW YORK, NY, 10019
- Phone: 6467479100
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Stephen Rocamboli | Director | New York, NY |
| Jason Stein | Director | New York, NY |
| Michael Weiser | Director | Los Angles, CA |
| Jason Stein | Executive Officer | New York, NY |
| Michael Weiser | Executive Officer | Los Angles, CA |
Other filings by this issuer (1)
More